Akebia filed its Investigational New Drug Application with the U.S. Food and Drug Administration (FDA) and recently initiated ...
Black coffee supports liver health and may lower disease risk. A gastroenterologist advises having two to three cups daily ...
A new scoring system using common clinical parameters accurately identifies chronic liver disease patients with a ...
GLP-RAs significantly improved liver histology, liver fat, and metabolic markers in patients with MASLD, outperforming DDP-4 inhibitors but increasing mild GI side effects.
In 2024, the U.S. FDA granted HYRNUO Breakthrough Therapy designation for the treatment of adult patients with unresectable or metastatic NSCLC whose tumors have activating HER2 (ERBB2) mutations, and ...
Both chicken and mutton are great sources of protein. But that is not the only substance they contain. Here is a closer look ...
Thanks, Jason, and thanks to all of you who have tuned in for today's call. Since the start of 2024, we've been enrolling ...
“Some people have no early symptoms, so blood test abnormalities (ALT/AST, bilirubin, INR) after starting a supplement also warrant stopping and evaluation,” adds Rissetto. Of all of the symptoms, ...
Dr. Christopher Kelly: A biomarker is a biological substance that can be objectively measured and tracked to provide ...
Kygevvi is expected to be commercially available in the US in the first quarter of 2026. The Food and Drug Administration (FDA) has approved Kygevvi ® for the treatment of thymidine kinase 2 ...
The therapeutic landscape for hepatocellular carcinoma (HCC) has been revolutionized by the advent of molecular targeted therapies and immune ...